Safety and Efficacy of Miglustat in Chinese NPC Patients

Clinical trial NCT03910621 · COMPLETED

Trial details

NCT number: NCT03910621
Sponsor: Actelion
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Niemann-Pick Disease, Type C

Start date: 2020-04-02
Primary completion: 2022-03-25
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.